Bayer AG (FRA:BAYN) has been assigned a €110.00 ($122.22) target price by investment analysts at Commerzbank AG in a report released on Wednesday. The brokerage currently has a a “buy” rating on the stock.

A number of other analysts have also recently issued reports on BAYN. Nord/LB set a €112.00 ($124.44) target price on Bayer AG and gave the stock a “buy” rating in a report on Wednesday. Warburg Research set a €118.00 ($131.11) price target on Bayer AG and gave the stock a “buy” rating in a research report on Wednesday. S&P Global Inc. set a €120.00 ($133.33) price target on Bayer AG and gave the stock a “buy” rating in a research report on Tuesday. BNP Paribas set a €105.00 ($116.67) price target on Bayer AG and gave the stock a “neutral” rating in a research report on Friday, July 15th. Finally, Goldman Sachs Group Inc. set a €129.00 ($143.33) price target on Bayer AG and gave the stock a “buy” rating in a research report on Thursday, June 2nd. Two research analysts have rated the stock with a sell rating, ten have assigned a hold rating and thirteen have given a buy rating to the stock. Bayer AG currently has an average rating of “Hold” and an average target price of €112.17 ($124.63).

Bayer AG (FRA:BAYN) opened at 92.80 on Wednesday. Bayer AG has a 12 month low of €83.87 and a 12 month high of €127.21. The stock has a market capitalization of €76.74 billion and a price-to-earnings ratio of 17.04. The stock’s 50 day moving average is €95.47 and its 200-day moving average is €95.90.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/21/bayer-ag-bayn-given-a-110-00-price-target-at-commerzbank-ag.html

Bayer AG Company Profile

.

Receive News & Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related companies with MarketBeat.com's FREE daily email newsletter.